Francisco Javier Teigell Muñoz
YOU?
Author Swipe
View article: Correction: PARP inhibitors‑associated thrombosis in patients with ovarian cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group
Correction: PARP inhibitors‑associated thrombosis in patients with ovarian cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group Open
View article: PARP inhibitors-associated thrombosis in patients with ovarian cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group
PARP inhibitors-associated thrombosis in patients with ovarian cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group Open
BRCA2 mutations could be a significant predictor for VTE/AT among ovarian cancer patients treated with iPARP. Concomitant treatment with bevacizumab may offer protection against thrombotic events, although a concomitant bias cannot be rule…
View article: Dalbavancin for Successful Treatment of Infective Endocarditis Caused by Enterococcus faecalis
Dalbavancin for Successful Treatment of Infective Endocarditis Caused by Enterococcus faecalis Open
Infective endocarditis is a relatively uncommon infection that requires a high index of suspicion, which can sometimes delay its diagnosis. It requires several weeks of intravenous antibiotics, which traditionally requires long hospital st…
View article: C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19
C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19 Open
View article: The Use of Corticosteroids or Tocilizumab in COVID-19 Based on Inflammatory Markers
The Use of Corticosteroids or Tocilizumab in COVID-19 Based on Inflammatory Markers Open
View article: A case‐control analysis of stroke in COVID‐19 patients: Results of unusual manifestations of COVID‐19–study 11
A case‐control analysis of stroke in COVID‐19 patients: Results of unusual manifestations of COVID‐19–study 11 Open
Objective We investigated the incidence, predictor variables, clinical characteristics, and stroke outcomes in patients with COVID‐19 seen in emergency departments (EDs) before hospitalization. Methods We retrospectively reviewed all COVID…
View article: Does timing matter on tocilizumab administration? Clinical, analytical and radiological outcomes in COVID-19
Does timing matter on tocilizumab administration? Clinical, analytical and radiological outcomes in COVID-19 Open
To our knowledge, this is the first report of data regarding the timing of administration of tocilizumab in patients with COVID-19 pneumonia. A strategy involving tocilizumab administration after 10 days from onset of symptoms may decrease…
View article: A safe protocol to identify low-risk patients with COVID-19 pneumonia for outpatient management
A safe protocol to identify low-risk patients with COVID-19 pneumonia for outpatient management Open
View article: Comparison of Lung Ultrasound versus Chest X-ray for Detection of Pulmonary Infiltrates in COVID-19
Comparison of Lung Ultrasound versus Chest X-ray for Detection of Pulmonary Infiltrates in COVID-19 Open
Point-of-care lung ultrasound (LUS) is an attractive alternative to chest X-ray (CXR), but its diagnostic accuracy compared to CXR has not been well studied in coronavirus disease 2019 (COVID-19) patients. We conducted a prospective observ…
View article: Frequency of five cardiovascular/hemostatic entities as primary manifestations of SARS-CoV-2 infection: Results of the UMC-19-S2
Frequency of five cardiovascular/hemostatic entities as primary manifestations of SARS-CoV-2 infection: Results of the UMC-19-S2 Open
View article: A safe protocol to identify low risk patients with COVID-19 pneumonia for outpatient management
A safe protocol to identify low risk patients with COVID-19 pneumonia for outpatient management Open
Background The coronavirus disease 2019 (COVID-19) outbreak has made necessary to rationalize health-care resources, but there are no published data to this moment regarding ambulatory management of patients with COVID-19 pneumonia. Object…
View article: A case‐control emergency department‐based analysis of acute pancreatitis in Covid‐19: Results of the UMC‐19‐S<sub>6</sub>
A case‐control emergency department‐based analysis of acute pancreatitis in Covid‐19: Results of the UMC‐19‐S<sub>6</sub> Open
Background/Purpose We investigated the incidence, risk factors, clinical characteristics and outcomes of acute pancreatitis (AP) in patients with COVID‐19 attending the emergency department (ED), before hospitalization. Methods We retrospe…